查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1904627

2032年醫學影像和放射技術進步市場預測：按模式、技術、應用、最終用戶和地區分類的全球分析

Medical Imaging & Radiology Advances Market Forecasts to 2032 - Global Analysis By Modality, Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的一項研究，預計到 2025 年，全球醫學影像和放射學進步市場規模將達到 438 億美元，到 2032 年將達到 628.8 億美元，預測期內複合年成長率為 5.3%。

醫學影像和放射學的進步是指開發和應用各種技術來視覺化人體內部結構和功能，以用於診斷、治療計劃和疾病監測。此領域涵蓋的影像方式包括X光、CT（電腦斷層掃描）、MRI（磁振造影）、超音波、PET（正子斷層掃描）和核子醫學影像等。這些進步主要集中在提高影像解析度、降低輻射暴露、提高診斷準確性以及實現即時成像等方面。人工智慧、3D影像和微創手術的整合進一步最佳化了患者照護，有助於疾病的早期發現，並促進在各種醫療環境中實施個人化治療策略。

慢性疾病負擔日益加重

癌症、心血管疾病和神經系統疾病等慢性病的日益普遍，推動了對先進醫學影像和放射學解決方案的需求。早期準確診斷在疾病管理和治療方案製定中發揮至關重要的作用，促使醫療機構採用尖端成像技術。隨著人口老化和文明病的增加，對精準、非侵入性診斷方法的需求日益成長，而醫學影像技術的進步正逐漸成為改善患者預後和降低長期醫療成本的重要工具。

高成本

先進醫學影像技術的應用受到設備購置、安裝和持續維護所需巨額資本投入的限制。高昂的營運成本，包括校準、軟體更新和專業人員人員編制，進一步限制了市場發展，尤其是在發展中地區。儘管臨床效益顯著，但小規模的醫療機構往往難以證明這些支出的合理性。因此，成本因素限制了技術的廣泛應用，減緩了其普及速度，並為製造商和醫療服務提供者帶來了嚴峻挑戰。

技術進步

持續的技術創新為該領域創造了巨大的成長機會。人工智慧 (AI)、機器學習和 3D 成像技術的融合，提高了診斷準確率，縮短了解讀時間，並實現了個人化治療方案的發展。此外，低劑量輻射技術、攜帶式成像設備和微創手術的發展，拓展了臨床應用範圍。這些進步使醫療服務提供者能夠提供更精準、高效、以患者為中心的服務，並將技術打造為市場擴張的關鍵驅動力。

監理和合規挑戰

嚴格的法規結構和合規要求給市場帶來了持續的挑戰。製造商必須應對全球各地衛生監管機構制定的複雜核准流程、品質標準和安全通訊協定。法規核准的延誤會阻礙產品上市，增加研發成本並限制市場進入。此外，不斷變化的病患資料隱私和輻射安全指南也需要持續監測和調整。這些因素會造成營運和財務壓力，並可能減緩創新步伐。

新冠疫情的影響

新冠疫情對醫學影像和放射學市場產生了雙重影響。初期，非緊急影像檢查被推遲，導致市場活動暫時減少。然而，乳房攝影篩檢，特別是X光和電腦斷層掃描，需求激增，用於診斷新冠肺炎和監測肺部併發症。疫情也加速了遠距放射學和基於人工智慧的診斷工具的應用，以最大限度地減少患者接觸並提高工作流程效率。總而言之，新冠疫情凸顯了先進影像技術在未來投資和技術應用策略中將扮演的重要角色。

預計在預測期內，核醫影像領域將佔據最大的市場佔有率。

由於核醫學影像在檢測和後續觀察包括癌症和神經系統疾病在內的複雜疾病方面發揮著至關重要的作用，預計在預測期內，核醫學影像領域將佔據最大的市場佔有率。 PET 和 SPECT 等核醫學影像技術能夠提供高度靈敏的功能訊息，是解剖成像的強大補充。放射性藥物的持續創新和劑量最佳化進一步提升了其臨床效用。全球醫院和診斷中心對這些技術的日益普及，以及人們對早期疾病檢測益處的認知不斷提高，正在推動市場需求的持續成長。

預計在預測期內，診斷中心細分市場將呈現最高的複合年成長率。

預計在預測期內，診斷中心領域將實現最高成長率，因為這些中心能夠在一個屋簷下提供多種影像檢查方式，從而實現高效的診斷和後續觀察。不斷提高的健康意識、對門診就醫的偏好以及經濟實惠的服務，都促進了患者群體的擴大。此外，與醫院的合作以及遠距放射學的整合，使得影像分析和報告能夠快速進行。因此，診斷中心正在成為先進影像技術和市場成長的關鍵樞紐。

比最大的地區

由於患者對早期診斷的意識提升不斷提高，亞太地區預計將在預測期內保持最大的市場佔有率。私人醫療機構的擴張和政府為改善醫療服務所採取的舉措，都促進了市場滲透。快速的都市化、可支配收入的成長以及保險覆蓋範圍的擴大，進一步推動了先進成像技術的應用。此外，對培養專業放射科醫生和建立診斷中心的投資，增強了該地區實施尖端影像解決方案的能力，從而鞏固了其作為主要市場貢獻者的地位。

複合年均成長率最高的地區

在預測期內，北美地區預計將實現最高的複合年成長率，這得益於其先進的基礎設施、健全的醫保政策和強勁的舉措。對精準醫療、疾病早期檢測和微創手術的日益重視，正在推動下一代影像技術的應用。此外，完善的診斷網路和對創新技術的監管支持，也促進了技術的快速商業化，使北美成為全球醫學影像放射學領域的重要成長中心。

關於免費客製化服務

購買此報告的客戶可享有以下免費自訂選項之一：

  • 公司概況
    • 最多三家新增市場參與企業進行全面分析
    • 主要企業SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶要求，對主要國家進行市場估算和預測，並計算複合年成長率（註：可行性需確認）。
  • 競爭標竿分析
    • 從產品系列、地域覆蓋範圍和策略聯盟等方面對主要參與企業進行基準分析

目錄

第1章執行摘要

第2章 前言

  • 摘要
  • 相關利益者
  • 調查範圍
  • 調查方法
  • 研究材料

第3章 市場趨勢分析

  • 促進要素
  • 抑制因素
  • 機會
  • 威脅
  • 技術分析
  • 應用分析
  • 終端用戶分析
  • 新興市場
  • 新冠疫情的感染疾病

第4章 波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

5. 全球醫學影像和放射技術進步市場（按模式分類）

  • X光影像
    • 數位X光
    • 可攜式X光機
    • 模擬X光
  • 超音波成像
    • 2D超音波
    • 多普勒超音波
    • 3D/4D超音波
  • 磁振造影（MRI）
    • 低場磁振造影
    • 高場磁振造影
    • 中場磁振造影
  • 電腦斷層掃描（CT）
  • 核子醫學影像
  • 其他方式

6. 全球醫學影像與放射技術進步市場

  • 影像處理中的人工智慧
  • 基於雲端的成像解決方案
  • 3D和4D成像
  • 可攜式和照護現場成像
  • 混合影像（PET/CT、PET/MRI）

7. 全球醫學影像和放射技術進步市場（按應用領域分類）

  • 診斷影像
  • 治療性介入影像
  • 研究和臨床試驗

8. 全球醫學影像和放射技術進步市場（按最終用戶分類）

  • 醫院
  • 研究所
  • 診斷中心
  • 門診手術中心

9. 全球醫療影像和放射技術進步市場（按地區分類）

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 亞太其他地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第10章：重大進展

  • 協議、夥伴關係、合作和合資企業
  • 併購
  • 新產品發布
  • 業務拓展
  • 其他關鍵策略

第11章 企業概況

  • GE HealthCare
  • Agfa Gevaert Group
  • Siemens Healthineers
  • Mindray Medical International Limited
  • Philips Healthcare
  • Neusoft Medical Systems Co., Ltd.
  • Canon Medical Systems Corporation
  • Carestream Health
  • Fujifilm Holdings Corporation
  • Konica Minolta Healthcare
  • Hologic, Inc.
  • Bracco Imaging
  • Hitachi Medical Systems
  • Esaote SpA
  • Samsung Medison
Product Code: SMRC32991

According to Stratistics MRC, the Global Medical Imaging & Radiology Advances Market is accounted for $43.80 billion in 2025 and is expected to reach $62.88 billion by 2032 growing at a CAGR of 5.3% during the forecast period. Medical imaging and radiology advances encompass the development and application of technologies that visualize the internal structures and functions of the body for diagnosis, treatment planning, and monitoring of diseases. This field includes modalities such as X-ray, CT (computed tomography), MRI (magnetic resonance imaging), ultrasound, PET (positron emission tomography), and nuclear imaging. Advances focus on improving image resolution, reducing radiation exposure, enhancing diagnostic accuracy, and enabling real-time imaging. Integration with artificial intelligence, 3D imaging, and minimally invasive procedures further optimizes patient care, supports early disease detection, and facilitates personalized treatment strategies across healthcare settings.

Market Dynamics:

Driver:

Increasing Burden of Chronic Diseases

The rising prevalence of chronic diseases such as cancer, cardiovascular disorders, and neurological conditions is fueling the demand for advanced medical imaging and radiology solutions. Early and accurate diagnosis plays a critical role in disease management and treatment planning, driving healthcare providers to adopt cutting-edge imaging technologies. As population's age and lifestyle-related disorders increase, the need for precise, non-invasive diagnostic modalities grows, positioning medical imaging advances as essential tools for improving patient outcomes and reducing long-term healthcare costs.

Restraint:

High Cost of Equipment & Maintenance

The adoption of advanced medical imaging technologies is hindered by the substantial capital investment required for equipment procurement, installation, and ongoing maintenance. High operational costs, including calibration, software updates, and specialized staffing, further constrain the market, particularly in developing regions. Smaller healthcare facilities often struggle to justify these expenditures despite the clinical benefits. Consequently, cost considerations limit widespread accessibility, slowing the pace of adoption and presenting a significant challenge for manufacturers and healthcare providers.

Opportunity:

Advancements in technology

Continuous technological innovation presents significant growth opportunities within the sector. Integration of artificial intelligence, machine learning, and 3D imaging enhances diagnostic accuracy, reduces interpretation time, and enables personalized treatment planning. Moreover, developments in low-dose radiation techniques, portable imaging devices, and minimally invasive procedures expand clinical applications. These advancements allow healthcare providers to deliver more precise, efficient, and patient-friendly services, positioning technology as a pivotal driver for market expansion.

Threat:

Regulatory & Compliance Challenges

Stringent regulatory frameworks and compliance requirements pose ongoing challenges for the market. Manufacturers must navigate complex approvals, quality standards, and safety protocols imposed by global health authorities. Delays in regulatory clearance can hinder product launches, increase development costs, and limit market entry. Additionally, evolving guidelines around patient data privacy and radiation safety necessitate continuous monitoring and adaptation. These factors create operational and financial pressures, potentially slowing innovation.

Covid-19 Impact:

The COVID-19 pandemic had a dual impact on the medical imaging and radiology market. Initially, non-essential imaging procedures were postponed, temporarily reducing market activity. However, demand for chest imaging, particularly X-rays and CT scans, surged for COVID-19 diagnosis and monitoring of pulmonary complications. The pandemic accelerated the adoption of tele-radiology and AI-based diagnostic tools to minimize patient contact and enhance workflow efficiency. Overall, COVID-19 highlighted the critical role of advanced imaging shaping future investment and technology deployment strategies.

The nuclear imaging segment is expected to be the largest during the forecast period

The nuclear imaging segment is expected to account for the largest market share during the forecast period, due to its critical role in detecting and monitoring complex diseases, including cancer and neurological conditions. Nuclear imaging techniques, such as PET and SPECT, provide highly sensitive functional information that complements anatomical imaging. Continuous innovations in radiopharmaceuticals and dose optimization have further enhanced clinical utility. Growing adoption in hospitals and diagnostic centers globally, coupled with increasing awareness of early disease detection benefits, drives sustained demand.

The diagnostic centers segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the diagnostic centers segment is predicted to witness the highest growth rate, as these centers offer a wide range of imaging modalities under one roof, facilitating efficient diagnosis and follow-up care. Rising health awareness, outpatient care preference, and cost-effective services contribute to the expanding patient base. Additionally, partnerships with hospitals and tele-radiology integration enable rapid image analysis and reporting. Consequently, diagnostic centers are emerging as critical hubs for advanced imaging adoption and market growth.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share, due to growing patient awareness of early diagnosis. Expanding private healthcare facilities and government initiatives to enhance medical services contribute to market penetration. Rapid urbanization, higher disposable incomes, and improved insurance coverage further support adoption of advanced imaging technologies. Moreover, investments in training skilled radiologists and establishing diagnostic centers strengthen the region's capacity to implement cutting-edge imaging solutions, consolidating its position as a leading market contributor.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to region benefits from advanced infrastructure, robust reimbursement policies, and strong research and development initiatives. Increased focus on precision medicine, early disease detection, and minimally invasive procedures encourages integration of next-generation imaging modalities. Additionally, well-established diagnostic networks and regulatory support for innovative technologies facilitate rapid commercialization, making North America a key growth hotspot in the global medical imaging and radiology advances.

Key players in the market

Some of the key players in Medical Imaging & Radiology Advances Market include GE HealthCare, Agfa-Gevaert Group, Siemens Healthineers, Mindray Medical International Limited, Philips Healthcare, Neusoft Medical Systems Co., Ltd., Canon Medical Systems Corporation, Carestream Health, Fujifilm Holdings Corporation, Konica Minolta Healthcare, Hologic, Inc., Bracco Imaging, Hitachi Medical Systems, Esaote SpA and Samsung Medison.

Key Developments:

In November 2025, Siemens Healthineers introduced Syngo Carbon 2.0, an upgraded enterprise imaging platform. The launch integrates multimodal imaging data, AI-powered workflow automation, and cloud-based collaboration, designed to streamline radiology operations and improve diagnostic accuracy across global healthcare systems.

In October 2025, Siemens Healthineers expanded its collaboration with Varian and multiple oncology centers to accelerate precision therapy solutions. The joint venture integrates imaging, radiation therapy, and AI-driven planning tools, aiming to improve cancer treatment outcomes and strengthen Siemens' leadership in oncology care.

Modalities Covered:

  • X-Ray Imaging
  • Ultrasound Imaging
  • Magnetic Resonance Imaging (MRI)
  • Computed Tomography (CT)
  • Nuclear Imaging
  • Other Modalities

Technologies Covered:

  • Artificial Intelligence in Imaging
  • Cloud-based Imaging Solutions
  • 3D & 4D Imaging
  • Portable & Point-of-Care Imaging
  • Hybrid Imaging (PET/CT, PET/MRI)

Applications Covered:

  • Diagnostic Imaging
  • Therapeutic/Interventional Imaging
  • Research & Clinical Trials

End Users Covered:

  • Hospitals
  • Research Institutes
  • Diagnostic Centers
  • Ambulatory Surgical Centers

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Medical Imaging & Radiology Advances Market, By Modality

  • 5.1 Introduction
  • 5.2 X-Ray Imaging
    • 5.2.1 Digital X-Ray
    • 5.2.2 Portable X-Ray
    • 5.2.3 Analog X-Ray
  • 5.3 Ultrasound Imaging
    • 5.3.1 2D Ultrasound
    • 5.3.2 Doppler Ultrasound
    • 5.3.3 3D/4D Ultrasound
  • 5.4 Magnetic Resonance Imaging (MRI)
    • 5.4.1 Low-field MRI
    • 5.4.2 High-field MRI
    • 5.4.3 Mid-field MRI
  • 5.5 Computed Tomography (CT)
  • 5.6 Nuclear Imaging
  • 5.7 Other Modalities

6 Global Medical Imaging & Radiology Advances Market, By Technology

  • 6.1 Introduction
  • 6.2 Artificial Intelligence in Imaging
  • 6.3 Cloud-based Imaging Solutions
  • 6.4 3D & 4D Imaging
  • 6.5 Portable & Point-of-Care Imaging
  • 6.6 Hybrid Imaging (PET/CT, PET/MRI)

7 Global Medical Imaging & Radiology Advances Market, By Application

  • 7.1 Introduction
  • 7.2 Diagnostic Imaging
  • 7.3 Therapeutic/Interventional Imaging
  • 7.4 Research & Clinical Trials

8 Global Medical Imaging & Radiology Advances Market, By End User

  • 8.1 Introduction
  • 8.2 Hospitals
  • 8.3 Research Institutes
  • 8.4 Diagnostic Centers
  • 8.5 Ambulatory Surgical Centers

9 Global Medical Imaging & Radiology Advances Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 GE HealthCare
  • 11.2 Agfa Gevaert Group
  • 11.3 Siemens Healthineers
  • 11.4 Mindray Medical International Limited
  • 11.5 Philips Healthcare
  • 11.6 Neusoft Medical Systems Co., Ltd.
  • 11.7 Canon Medical Systems Corporation
  • 11.8 Carestream Health
  • 11.9 Fujifilm Holdings Corporation
  • 11.10 Konica Minolta Healthcare
  • 11.11 Hologic, Inc.
  • 11.12 Bracco Imaging
  • 11.13 Hitachi Medical Systems
  • 11.14 Esaote SpA
  • 11.15 Samsung Medison

List of Tables

  • Table 1 Global Medical Imaging & Radiology Advances Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Medical Imaging & Radiology Advances Market Outlook, By Modality (2024-2032) ($MN)
  • Table 3 Global Medical Imaging & Radiology Advances Market Outlook, By X-Ray Imaging (2024-2032) ($MN)
  • Table 4 Global Medical Imaging & Radiology Advances Market Outlook, By Digital X-Ray (2024-2032) ($MN)
  • Table 5 Global Medical Imaging & Radiology Advances Market Outlook, By Portable X-Ray (2024-2032) ($MN)
  • Table 6 Global Medical Imaging & Radiology Advances Market Outlook, By Analog X-Ray (2024-2032) ($MN)
  • Table 7 Global Medical Imaging & Radiology Advances Market Outlook, By Ultrasound Imaging (2024-2032) ($MN)
  • Table 8 Global Medical Imaging & Radiology Advances Market Outlook, By 2D Ultrasound (2024-2032) ($MN)
  • Table 9 Global Medical Imaging & Radiology Advances Market Outlook, By Doppler Ultrasound (2024-2032) ($MN)
  • Table 10 Global Medical Imaging & Radiology Advances Market Outlook, By 3D/4D Ultrasound (2024-2032) ($MN)
  • Table 11 Global Medical Imaging & Radiology Advances Market Outlook, By Magnetic Resonance Imaging (MRI) (2024-2032) ($MN)
  • Table 12 Global Medical Imaging & Radiology Advances Market Outlook, By Low-field MRI (2024-2032) ($MN)
  • Table 13 Global Medical Imaging & Radiology Advances Market Outlook, By High-field MRI (2024-2032) ($MN)
  • Table 14 Global Medical Imaging & Radiology Advances Market Outlook, By Mid-field MRI (2024-2032) ($MN)
  • Table 15 Global Medical Imaging & Radiology Advances Market Outlook, By Computed Tomography (CT) (2024-2032) ($MN)
  • Table 16 Global Medical Imaging & Radiology Advances Market Outlook, By Nuclear Imaging (2024-2032) ($MN)
  • Table 17 Global Medical Imaging & Radiology Advances Market Outlook, By Other Modalities (2024-2032) ($MN)
  • Table 18 Global Medical Imaging & Radiology Advances Market Outlook, By Technology (2024-2032) ($MN)
  • Table 19 Global Medical Imaging & Radiology Advances Market Outlook, By Artificial Intelligence in Imaging (2024-2032) ($MN)
  • Table 20 Global Medical Imaging & Radiology Advances Market Outlook, By Cloud-based Imaging Solutions (2024-2032) ($MN)
  • Table 21 Global Medical Imaging & Radiology Advances Market Outlook, By 3D & 4D Imaging (2024-2032) ($MN)
  • Table 22 Global Medical Imaging & Radiology Advances Market Outlook, By Portable & Point-of-Care Imaging (2024-2032) ($MN)
  • Table 23 Global Medical Imaging & Radiology Advances Market Outlook, By Hybrid Imaging (PET/CT, PET/MRI) (2024-2032) ($MN)
  • Table 24 Global Medical Imaging & Radiology Advances Market Outlook, By Application (2024-2032) ($MN)
  • Table 25 Global Medical Imaging & Radiology Advances Market Outlook, By Diagnostic Imaging (2024-2032) ($MN)
  • Table 26 Global Medical Imaging & Radiology Advances Market Outlook, By Therapeutic/Interventional Imaging (2024-2032) ($MN)
  • Table 27 Global Medical Imaging & Radiology Advances Market Outlook, By Research & Clinical Trials (2024-2032) ($MN)
  • Table 28 Global Medical Imaging & Radiology Advances Market Outlook, By End User (2024-2032) ($MN)
  • Table 29 Global Medical Imaging & Radiology Advances Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 30 Global Medical Imaging & Radiology Advances Market Outlook, By Research Institutes (2024-2032) ($MN)
  • Table 31 Global Medical Imaging & Radiology Advances Market Outlook, By Diagnostic Centers (2024-2032) ($MN)
  • Table 32 Global Medical Imaging & Radiology Advances Market Outlook, By Ambulatory Surgical Centers (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.